Healthcare compliance
Medicare Part D Payment Data Gap: What HHS OIG Could Not Trace
HHS OIG found similar net drug costs for selected Medicare Part D drugs, but different payment paths and incomplete pharmacy-level DIR traceability.
Healthcare compliance
HHS OIG found similar net drug costs for selected Medicare Part D drugs, but different payment paths and incomplete pharmacy-level DIR traceability.
Healthcare compliance
H.R. 8871 would create a 90-day claims-submission period for certain Medicare DME items and require GAO to examine MAC screening technology.